Patients with hepatocellular carcinoma (HCC) can be offered transarterial radioembolization (TARE) as a safe and…
View More Good Survival, Outcomes With TARE for HCCHome »
Europe Approves Pemigatinib for Bile Duct Cancer
The European Commission has approved the oral targeted therapy pemigatinib (Pemazyre) for the treatment of…
View More Europe Approves Pemigatinib for Bile Duct Cancer